GAGA Share Market News

[hfe_template id='11223'] [ad_1] Shares of Dr. Reddy’s Laboratories are expected to be in focus in Tuesday’s trading session after the company issued a clarification denying recent media reports about a major workforce cost cut. In an exchange filing, the pharmaceutical major responded to a news article published in Business Standard on April 13, which claimed that Dr. Reddy’s had reduced its workforce costs by 25% amid margin pressures linked to Revlimid. The company categorically denied the claim, stating the news item is “factually incorrect” and that it “categorically denies” both the reported workforce cost reduction and the other assertions made in the article. “This is in reference to Regulation 30(11) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) regarding a news item published in Business Standard (newspaper/ media) on April 13, 2025, with the heading “DRL trims workforce costs by 25% amid Revlimid-l...

[hfe_template id='11223'] [ad_1] Shares of the IPO-bound National Stock Exchange of India will be easily transferable between investors starting Monday, as the bourse moves from an exchange approval-based system to the delivery instruction slip (DIS) mechanism. The shift is expected to shrink share-transfer timelines from as long as six months to just 3 to 5 days, streamlining transactions in the highly sought-after unlisted market. “Given Sebi’s circular dated October 14, 2024, the ISIN of NSE will be activated/unfrozen with effect from Monday, March 24,” the exchange said in a message to shareholders. “Accordingly, from Monday, the shares of NSE can be transferred through the DIS mechanism without following the existing Stage 1/Stage 2 process.” Under the existing system, share transfers require a two-stage process—first, a know-your-customer (KYC) check, followed by a “fit and proper” assessment. The exchange has been conducting these checks manually, causing signific...

[hfe_template id='11223'] [ad_1] Mumbai: UltraTech Cement's open offer for subsidiary India Cements has seen a rare oversubscription, thanks to its high offer price. Less than 5% open offers launched since 2015 in the country have been fully subscribed, data compiled by ET showed. The ₹390-per-share offer, open from January 8 to 21, was subscribed 110%. It will increase UltraTech's stake in India Cements to 81.49%. India Cements' shares closed at ₹295.15 on Friday, marking a nearly 22% gain in a year. "They were offering a very good value compared to the price at which they bought from the Damanis. So, ideally, anyone who has bought the shares at Rs 300 or below would like to tender their shares," said Mangesh Bhadang, analyst at Centrum Broking. UltraTech will now have to pare its holding in India Cements to less than 75% to comply with market regulator Securities and Exchange Board of India's minimum public shareholding norms. "We will no...

[hfe_template id='11223'] [ad_1] Shares of BN Rathi Securities may remain in attention on Thursday, January 23, as today marks the last day to buy the stock in order to qualify for its announced 1:1 bonus share issue as well as the 1:2 stock split. The company had fixed January 24 as the record date for the purpose of determining eligible shareholders for both corporate actions. Therefore, to qualify for the benefits of these corporate actions, investors’ names must appear in the company’s book as of today. Here are the details of the said corporate actions: 1:1 Bonus issue The board of BN Rathi Securities announced a 1:1 bonus share issue, which means that the company will be issuing one additional share for every share already held by its shareholders. “Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 Company has fixed Friday, 24", January, 2025 as the Record Date, for the purpose of ascertaining the eligib...